The Valley Hospital Now Provides Full Suite of Novel Atrial Fibrillation Treatment Technologies
PARAMUS, NJ, July 2, 2024 – The Valley Hospital is pleased to expand its ablation techniques for patients diagnosed with atrial fibrillation (AFib) and is now offering the Farapulse? Pulsed Field Ablation (PFA) System, manufactured by Boston Scientific. The Farapulse System uses pulsed electrical fields, rather than thermal ablation, similar to the PulseSelect? PFA System, recently introduced at Valley.
The Farapulse PFA system sends pulsed electric fields through an ablation catheter designed specifically to interrupt irregular electrical pathways in the heart that trigger AFib. Current ablation technologies rely on thermal effects to target cardiac tissue. PFA’s pulsed electric fields efficiently isolate pulmonary veins. This approach, rather than thermal ablation, can result in a lower risk of collateral tissue being impacted during treatment.
“The Valley Hospital is proud to provide comprehensive treatment for atrial fibrillation,” said Suneet Mittal, MD, Director of Electrophysiology at The Valley Hospital, Medical Director of The Snyder Center for Comprehensive Atrial Fibrillation at The Valley Hospital, and Chair of the Cardiovascular Service Line for Valley Health System. “The Farapulse PFA System is yet another new advancement in the treatment of AFib, which improved procedural outcomes and reduced the change of damages to surrounding tissue. Our team is dedicated to researching and adopting the latest treatment technologies to enhance our care of this disease.”
According to the American Heart Association, more than 12 million Americans are expected to develop atrial fibrillation by the end of the decade. AFib is a serious condition that should not be left untreated. It can lead to blood clots, stroke, heart failure, and other heart-related complications.
To learn more about Valley’s electrophysiology services and the treatments available, please visit ValleyHealth.com/EP.
What's Related